Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APVO | AMGN | BMY | GILD | ILMN |
| Company | Aptevo Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7000 | 272.14 | 49.16 | 67.09 | 120.82 |
| High | 0.7480 | 273.81 | 49.47 | 67.68 | 124.45 |
| Low | 0.7000 | 271.05 | 48.96 | 67.07 | 120.82 |
| Last | 0.7320 | 272.08 | 49.33 | 67.31 | 125.04 |
| Change | +0.0220 | +0.17 | +0.19 | +0.36 | +4.79 |
| % Change | +3.10% | +0.06% | +0.39% | +0.54% | +3.98% |
| Volume | 67,662 | 96,812 | 458,591 | 359,698 | 90,745 |
| 20-Day Average Volume | 525,529 | 2,094,544 | 10,509,714 | 6,083,075 | 1,445,591 |
| Previous Close | 0.7100 | 271.91 | 49.14 | 66.95 | 120.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.4127 | 271.96 | 50.57 | 69.36 | 126.99 |
| 20-Day Raw Stochastic | 1.62% | 43.86% | 25.29% | 18.57% | 30.32% |
| 20-Day Relative Strength | 25.96% | 48.07% | 43.55% | 34.76% | 43.62% |
| Weighted Alpha | -94.22 | +11.10 | -24.99 | -20.29 | -37.12 |
| Today's Opinion | 100% Sell | 40% Sell | 88% Sell | 100% Sell | 88% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 88% Sell | 100% Sell | 72% Sell |
| Last Month's Opinion | 100% Sell | 8% Buy | 24% Sell | 88% Sell | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.65% since 04/16/24 | +2.74% since 04/16/24 | +2.26% since 04/16/24 | +0.10% since 04/16/24 | +4.61% since 04/16/24 |
| Low | 0.6700 on 04/22/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 0.7756 on 04/17/24 | 273.48 on 04/23/24 | 49.56 on 04/22/24 | 67.57 on 04/22/24 | 123.11 on 04/23/24 |
| 1-Month | |||||
| %Chg | -83.77% since 03/22/24 | -1.18% since 03/22/24 | -4.97% since 03/22/24 | -7.20% since 03/22/24 | -10.30% since 03/22/24 |
| Low | 0.6700 on 04/22/24 | 260.68 on 04/19/24 | 47.62 on 04/18/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 4.9979 on 03/28/24 | 288.57 on 03/28/24 | 54.47 on 03/28/24 | 73.87 on 03/28/24 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | -88.71% since 01/23/24 | -11.94% since 01/23/24 | -1.54% since 01/23/24 | -15.22% since 01/23/24 | -12.53% since 01/23/24 |
| Low | 0.6700 on 04/22/24 | 260.68 on 04/19/24 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 10.8000 on 03/07/24 | 329.72 on 02/05/24 | 55.03 on 03/13/24 | 81.06 on 01/25/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | -94.87% since 10/23/23 | -0.05% since 10/23/23 | -11.88% since 10/23/23 | -13.13% since 10/23/23 | +3.05% since 10/23/23 |
| Low | 0.6700 on 04/22/24 | 249.70 on 10/31/23 | 47.58 on 02/06/24 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 15.1448 on 10/26/23 | 329.72 on 02/05/24 | 56.77 on 10/25/23 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 304 | 145,845,984 | 99,594,944 | 83,357,904 | 19,150,414 |
| Shares Outstanding, K | 428 | 536,376 | 2,026,759 | 1,245,077 | 159,255 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -17,410,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 11,477,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | -5,900,000 | 767,000,000 | 1,762,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 4.89 | 0.58 | 0.39 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | -22.03 on 11/14/23 | 4.71 on 02/06/24 | 1.70 on 02/02/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 04/25/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.600 on 04/04/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 04/04/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.42 | 6.52 | 9.93 | 134.98 |